Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 9 | $38,088,067 |
Sells | 0 | $0 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Feb 2024 14:37 | LRMR | Larimar Therapeutics Inc | FLYNN JAMES E | Director , 10% | 16 Feb 2024 | Purchase | 1,430,206 | 8.74 | 12,500,000 | I |
16 Feb 2024 14:37 | LRMR | Larimar Therapeutics Inc | FLYNN JAMES E | Director , 10% | 16 Feb 2024 | Purchase | 1,430,205 | 8.74 | 12,499,992 | I |
16 Feb 2024 14:37 | LRMR | Larimar Therapeutics Inc | FLYNN JAMES E | Director , 10% | 16 Feb 2024 | Purchase | 1,430,206 | 8.74 | 12,500,000 | I |
15 Feb 2024 16:21 | LRMR | Larimar Therapeutics Inc | THOMAS FRANK E | Director | 14 Feb 2024 | Purchase | 2,000 | 11 | 22,000 | D |
08 Dec 2023 16:08 | LRMR | Larimar Therapeutics Inc | SHANKAR GOPI | Chief Development Officer | 07 Dec 2023 | Purchase | 5,000 | 3.7323 | 18,662 | D |
31 May 2024 16:56 | LRMR | Larimar Therapeutics Inc | HAMILTON THOMAS EDWARD | Director | 16 Feb 2024 | Purchase | 57,208 | 8.74 | 499,998 | D |
18 May 2023 14:12 | LRMR | Larimar Therapeutics Inc | TRUITT JOSEPH | Director | 17 May 2023 | Purchase | 2,750 | 3.73 | 10,258 | D |
18 May 2023 14:13 | LRMR | Larimar Therapeutics Inc | BEN-MAIMON CAROLE | President and CEO | 17 May 2023 | Purchase | 5,000 | 3.705 | 18,525 | D |
18 May 2023 14:13 | LRMR | Larimar Therapeutics Inc | CELANO MICHAEL | Chief Financial Officer | 17 May 2023 | Purchase | 5,000 | 3.7263 | 18,632 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)